Open access
Sep 2026
AAV-mediated SIL1 gene therapy prevents cerebellar degeneration and ataxia in a mouse model of Marinesco-Sjögren syndrome
Findings provide proof-of-principle that AAV-mediated SIL1 gene therapy can prevent the neurological and muscular manifestations of Marinesco-Sjögren syndrome and identify Purkinje cells as a critical cellular target for preventing cerebellar dysfunction.
Chiara Pasini, Giada Lavigna, Anna Grasso et al.
· bioRxiv · 0 citations